M13

Activity from announced rounds

Activity in this selectionUnited States · Oct 16, 2026 · Jul 19, 2026

M13 is the venture organization whose portfolio identifies Ayble Health and which OpenFX names in its Series A.

Recorded funding activity

Ayble supplies virtual digestive care. Rime develops conversational speech models, while Chord supplies commerce software. These company financings preserve distinct customer problems under the same firm identity.

Sources
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$16M
1 disclosed · full round size, not this investor’s share

By stage

Series A1

By primary sector

Healthtech1

By country

United States1

Rounds

1 in this selection
Ayble Health

Ayble Health is a virtual digestive-care clinic for people with gastrointestinal symptoms and chronic conditions. Its multidisciplinary care team combines medical visits, registered dietitians, pharmacists, behavioral-health support and coaching in a personalized care plan, with coverage through health plans and employer or health-system partnerships.

$16MSeries A
Participant